Title: Hormonal contraception and bone health.

POPLINE Document Number: 318979

Corporate Author(s):

World Health Organization [WHO]. Department of Reproductive Health and Research

Source citation:

Geneva, Switzerland, WHO, Department of Reproductive Health and Research, 2007. [2] p. (Provider Brief)

Abstract:

Hormonal contraceptives, which include birth control pills, injections, implants, the patch and the vaginal ring, all use hormones to keep a woman from getting pregnant. These hormones can have other health effects for women, many of them beneficial, besides just preventing pregnancy. However, some questions have been raised about how particular hormonal contraceptives, DMPA (depot medroxyprogesterone acetate with trade names of Depo-Provera, Depo-Clinovir and others) and NET-EN (norethisterone enantate or Noristerat, Norigest, Doryxas and others), may affect the health of women's bone. (excerpt)

Keywords:

Global
Recommendations
Evaluation
Women
Skeletal Effects
Depo-Provera
Oral Contraceptives, Combined
Side Effects
Osteoporosis
Progestins, Low-Dose
WHO
Age Factors
Demographic Factors
Population
Physiology
Biology
Medroxyprogesterone Acetate
Contraceptive Agents, Progestin
Contraceptive Agents, Female
Contraceptive Agents
Contraception
Family Planning
Oral Contraceptives
Contraceptive Methods
Treatment
Medical Procedures
Medicine
Health Services
Delivery of Health Care
Health
UN
International Agencies
Organizations
Political Factors
Sociocultural Factors
Population Characteristics